Histidine affinity tags affect MSP1 42 structural stability and immunodominance in mice

Biotechnology Journal

Volumn 7, Issue 1, 2012, Pages 133-147

  Khan, Farhat ^a   Legler, Patricia M ^b   Mease, Ryan M ^a   Duncan, Elizabeth H ^a   Bergmann Leitner, Elke S ^a   Angov, Evelina ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b NAVAL RESEARCH LABORATORY   (United States)

Author keywords

Histidine tag; Immune deviation; Immunodominance; Neo epitope; Protein structure

Indexed keywords

HISTIDINE TAG; IMMUNE DEVIATION; IMMUNODOMINANCE; NEO-EPITOPE; PROTEIN STRUCTURE;

AMINO ACIDS; ANTIGENS; CLONING; GENES; IMMUNOLOGY; MAMMALS; METAL IONS; PRODUCT DEVELOPMENT; PYROLYSIS; SOLUBILITY; STABILITY;

ANTIBODIES;

HISTIDINE; HISTIDINE AFFINITY TAG; MEROZOITE SURFACE PROTEIN 1; METAL ION; PROTEIN P19; PROTEIN P33; PROTEIN TAG; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CELLULAR IMMUNITY; CIRCULAR DICHROISM; CONTROLLED STUDY; GENE SEQUENCE; HUMORAL IMMUNITY; IMMUNITY; IMMUNOGENICITY; MOUSE; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN STABILITY; PROTEIN STRUCTURE; T LYMPHOCYTE;

AFFINITY LABELS; ANIMALS; ANTIBODIES, PROTOZOAN; HISTIDINE; IMMUNITY, CELLULAR; MALARIA VACCINES; MEROZOITE SURFACE PROTEIN 1; MICE; MICE, INBRED BALB C; PLASMODIUM FALCIPARUM; PROTEIN DENATURATION; PROTEIN FOLDING; PROTEIN STRUCTURE, SECONDARY; RECOMBINANT PROTEINS; SOLUBILITY; T-LYMPHOCYTES;

MUS; PLASMODIUM FALCIPARUM;

EID: 84855581646     PISSN: 18606768     EISSN: 18607314     Source Type: Journal    
DOI: 10.1002/biot.201100331     Document Type: Article

References (57)

1. Waugh, D. S., Making the most of affinity tags. Trends Biotechnol. 2005, 23, 316-320.
2. Arnau, J., Lauritzen, C., Petersen, G. E., Pedersen, J., Current strategies for the use of affinity tags and tag removal for the purification of recombinant proteins. Protein Expr. Purif. 2006, 48, 1-13.
3. Porath, J., Carlsson, J., Olsson, I., Belfrage, G., Metal chelate affinity chromatography, a new approach to protein fractionation. Nature 1975, 258, 598-599.
4. Hochuli, E., Large-scale chromatography of recombinant proteins. J. Chromatogr. 1988, 444, 293-302.
5. Clemmitt, R. H., Chase, H. A., Facilitated downstream processing of a histidine-tagged protein from unclarified E. coli homogenates using immobilized metal affinity expanded-bed adsorption. Biotechnol. Bioeng. 2000, 67, 206-216.
6. Block, H., Maertens, B., Spriestersbach, A., Brinker, N. et al., Immobilized-metal affinity chromatography (IMAC): A review. Methods Enzymol. 2009, 463, 439-473.
7. Goel, A., Colcher, D., Koo, J. S., Booth, B. J. et al., Relative position of the hexahistidine tag effects binding properties of a tumor-associated single-chain Fv construct. Biochim. Biophys. Acta 2000, 1523, 13-20.
8. Halliwell, C. M., Morgan, G., Ou, C. P., Cass, A. E., Introduction of a (poly)histidine tag in L-lactate dehydrogenase produces a mixture of active and inactive molecules. Anal. Biochem. 2001, 295, 257-261.
9. Woestenenk, E. A., Hammarstrom, M., van den Berg, S., Hard, T., Berglund, H., His tag effect on solubility of human proteins produced in Escherichia coli: A comparison between four expression vectors. J. Struct. Funct. Genomics 2004, 5, 217-229.
10. Chant, A., Kraemer-Pecore, C. M., Watkin, R., Kneale, G. G., Attachment of a histidine tag to the minimal zinc finger protein of the Aspergillus nidulans gene regulatory protein AreA causes a conformational change at the DNA-binding site. Protein Expr. Purif. 2005, 39, 152-159.
11. Arnau, J., Lauritzen, C., Petersen, G. E., Pedersen, J., The use of TAGZyme for the efficient removal of N-terminal His-tags. Methods Mol. Biol. 2008, 421, 229-243.
12. Kuo, W. H., Chase, H. A., Adsorptive detagging of poly-histidine tagged protein using hexa-histidine tagged exopeptidase. J. Chromatogr. A 2010, 1217, 7749-7758.
13. Kuo, W. H., Chase, H. A., Process intensification for the removal of poly-histidine fusion tags from recombinant proteins by an exopeptidase. Biotechnol. Prog. 2010, 26, 142-149.
14. Kenig, M., Peternel, S., Gaberc-Porekar, V., Menart, V., Influence of the protein oligomericity on final yield after affinity tag removal in purification of recombinant proteins. J. Chromatogr. A 2006, 1101, 293-306.
15. Kenig, M., Peternel, S., Gaberc-Porekar, V., Menart, V., Influence of the protein oligomericity on final yield after affinity tag removal in purification of recombinant proteins. J. Chromatogr. A 2006, 1101, 293-306.
16. Birkholtz, L. M., Blatch, G., Coetzer, T. L., Hoppe, H. C. et al., Heterologous expression of plasmodial proteins for structural studies and functional annotation. Malar. J. 2008, 7, 197.
17. Angov, E., Hillier, C. J., Kincaid, R. L., Lyon, J. A., Heterologous protein expression is enhanced by harmonizing the codon usage frequencies of the target gene with those of the expression host. PLoS One 2008, 3, e2189.
18. Angov, E., Codon usage: Nature's roadmap to expression and folding of proteins. Biotechnol. J. 2011, 6, 650-659.
19. Vulliet, R., Improved technique for the preparation of water-in-oil emulsions containing protein antigens. Biotechniques 1996, 20, 797-800.
20. Bergmann-Leitner, E. S., Duncan, E. H., Leitner, W. W., Neutzner, A. et al., C3d-defined complement receptor-binding peptide p28 conjugated to circumsporozoite protein provides protection against Plasmodium berghei. Vaccine 2007, 25, 7732-7736.
21. Bergmann-Leitner, E. S., Mease, R. M., Duncan, E. H., Khan, F. et al., Evaluation of immunoglobulin purification methods and their impact on quality and yield of antigen-specific antibodies. Malar. J. 2008, 7, 129.
22. Bergmann-Leitner, E. S., Duncan, E. H., Mullen, G. E., Burge, J. R. et al., Critical evaluation of different methods for measuring the functional activity of antibodies against malaria blood stage antigens. Am. J. Trop. Med. Hyg. 2006, 75, 437-442.
23. Bergmann-Leitner, E. S., Duncan, E. H., Burge, J. R., Spring, M., Angov, E., Miniaturization of a high-throughput pLDH-based Plasmodium falciparum growth inhibition assay for small volume samples from preclinical and clinical vaccine trials. Am. J. Trop. Med. Hyg. 2008, 78, 468-471.
24. Morgan, W. D., Birdsall, B., Frenkiel, T. A., Gradwell, M. G. et al., Solution structure of an EGF module pair from the Plasmodium falciparum merozoite surface protein 1. J. Mol. Biol. 1999, 289, 113-122.
25. Egan, A. F., Morris, J., Barnish, G., Allen, S. et al., Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1. J. Infect. Dis. 1996, 173, 765-769.
26. Blackman, M. J., Ling, I. T., Nicholls, S. C., Holder, A. A., Proteolytic processing of the Plasmodium falciparum merozoite surface protein-1 produces a membrane-bound fragment containing two epidermal growth factor-like domains. Mol. Biochem. Parasitol. 1991, 49, 29-33.
27. Blackman, M. J., Whittle, H., Holder, A. A., Processing of the Plasmodium falciparum major merozoite surface protein-1: Identification of a 33-kilodalton secondary processing product which is shed prior to erythrocyte invasion. Mol. Biochem. Parasitol. 1991, 49, 35-44.
28. Farley, P. J., Long, C. A., Plasmodium yoelii yoelii 17XL MSP-1: Fine-specificity mapping of a discontinuous, disulfide-dependent epitope recognized by a protective monoclonal antibody using expression PCR (E-PCR). Exp. Parasitol. 1995, 80, 328-332.
29. McBride, J. S., Heidrich, H. G., Fragments of the polymorphic Mr 185, 000 glycoprotein from the surface of isolated Plasmodium falciparum merozoites form an antigenic complex. Mol. Biochem. Parasitol. 1987, 23, 71-84.
30. Uthaipibull, C., Aufiero, B., Syed, S. E., Hansen, B. et al., Inhibitory and blocking monoclonal antibody epitopes on merozoite surface protein 1 of the malaria parasite Plasmodium falciparum. J. Mol. Biol. 2001, 307, 1381-1394.
31. Blackman, M. J., Heidrich, H. G., Donachie, S., McBride, J. S., Holder, A. A., A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies. J. Exp. Med. 1990, 172, 379-382.
32. Majarian, W. R., Daly, T. M., Weidanz, W. P., Long, C. A., Passive immunization against murine malaria with an IgG3 monoclonal antibody. J. Immunol. 1984, 132, 3131-3137.
33. Ling, I. T., Ogun, S. A., Holder, A. A., Immunization against malaria with a recombinant protein. Parasite Immunol. 1994, 16, 63-67.
34. Okech, B. A., Corran, P. H., Todd, J., Joynson-Hicks, A. et al., Fine specificity of serum antibodies to Plasmodium falciparum merozoite surface protein, PfMSP-1(19), predicts protection from malaria infection and high-density parasitemia. Infect. Immun. 2004, 72, 1557-1567.
35. Corran, P. H., O'Donnell, R. A., Todd, J., Uthaipibull, C. et al., The fine specificity, but not the invasion inhibitory activity, of 19-kilodalton merozoite surface protein 1-specific antibodies is associated with resistance to malarial parasitemia in a cross-sectional survey in The Gambia. Infect. Immun. 2004, 72, 6185-6189.
36. Courtin, D., Oesterholt, M., Huismans, H., Kusi, K. et al., The quantity and quality of African children's IgG responses to merozoite surface antigens reflect protection against Plasmodium falciparum malaria. PLoS One 2009, 4, e7590.
37. Derewenda, Z. S., The use of recombinant methods and molecular engineering in protein crystallization. Methods 2004, 34, 354-363.
38. Bondos, S. E., Bicknell, A., Detection and prevention of protein aggregation before, during, and after purification. Anal. Biochem. 2003, 316, 223-231.
39. Klose, J., Wendt, N., Kubald, S., Krause, E. et al., Hexa-histidin tag position influences disulfide structure but not binding behavior of in vitro folded N-terminal domain of rat corticotropin-releasing factor receptor type 2a. Protein Sci. 2004, 13, 2470-2475.
40. Korepanova, A., Douglas, C., Leyngold, I., Logan, T. M., N-terminal extension changes the folding mechanism of the FK506-binding protein. Protein Sci. 2001, 10, 1905-1910.
41. Kramer, G., Kudlicki, W., McCarthy, D., Tsalkova, T. et al., N-terminal and C-terminal modifications affect folding, release from the ribosomes and stability of in vitro synthesized proteins. Int. J. Biochem. Cell Biol. 1999, 31, 231-241.
42. Carson, M., Johnson, D. H., McDonald, H., Brouillette, C., Delucas, L. J., His-tag impact on structure. Acta Crystallogr. D Biol. Crystallogr. 2007, 63, 295-301.
43. Angov, E., Aufiero, B. M., Turgeon, A. M., Van Handenhove, M. et al., Development and pre-clinical analysis of a Plasmodium falciparum merozoite surface protein-1(42) malaria vaccine. Mol. Biochem. Parasitol. 2003, 128, 195-204.
44. Darko, C. A., Angov, E., Collins, W. E., Bergmann-Leitner, E. S. et al., The clinical-grade 42-kilodalton fragment of merozoite surface protein 1 of Plasmodium falciparum strain FVO expressed in Escherichia coli protects Aotus nancymai against challenge with homologous erythrocytic-stage parasites. Infect. Immun. 2005, 73, 287-297.
45. Ockenhouse, C. F., Angov, E., Kester, K. E., Diggs, C. et al., Phase I safety and immunogenicity trial of FMP1/AS02A, a Plasmodium falciparum MSP-1 asexual blood stage vaccine. Vaccine 2006, 24, 3009-3017.
46. Ling, Z., Tran, K. C., Arnold, J. J., Teng, M. N., Purification and characterization of recombinant human respiratory syncytial virus nonstructural protein NS1. Protein Expr. Purif. 2008, 57, 261-270.
47. Svensson, J., Andersson, C., Reseland, J. E., Lyngstadaas, P., Bulow, L., Histidine tag fusion increases expression levels of active recombinant amelogenin in Escherichia coli. Protein Expr. Purif. 2006, 48, 134-141.
48. Hamdane, D., Skouloubris, S., Myllykallio, H., Golinelli-Pimpaneau, B., Expression and purification of untagged and histidine-tagged folate-dependent tRNA:m5U54 methyltransferase from Bacillus subtilis. Protein Expr. Purif. 2010, 73, 83-89.
49. de Smit, M. H., van Duin, J., Control of prokaryotic translational initiation by mRNA secondary structure. Prog. Nucleic Acid Res. Mol. Biol. 1990, 38, 1-35.
50. de Smit, M. H., van Duin, J., Secondary structure of the ribosome binding site determines translational efficiency: A quantitative analysis. Proc. Natl. Acad. Sci. USA 1990, 87, 7668-7672.
51. Nakajima, S., Yanagihara, I., Ozono, K., A 65-kilodalton nuclear protein binds to the human vitamin D receptor: a bacterial-expressed histidine-tagged receptor study. Biochem. Biophys. Res. Commun. 1997, 232, 806-809.
52. Freydank, A. C., Brandt, W., Drager, B., Protein structure modeling indicates hexahistidine-tag interference with enzyme activity. Proteins 2008, 72, 173-183.
53. Song, J., Markley, J. L., Cautionary tail: The presence of an N-terminal tag on dynein light-chain Roadblock/LC7 affects its interaction with a functional partner. Protein Pept. Lett. 2007, 14, 265-268.
54. Yap, W. B., Tey, B. T., Ng, M. Y., Ong, S. T., Tan, W. S., N-terminally His-tagged hepatitis B core antigens: Construction, expression, purification and antigenicity. J. Virol. Methods 2009, 160, 125-131.
55. Kolaskar, A. S., Tongaonkar, P. C., A semi-empirical method for prediction of antigenic determinants on protein antigens. FEBS Lett. 1990, 276, 172-174.
56. Reche, P. A., Glutting, J. P., Reinherz, E. L., Prediction of MHC class I binding peptides using profile motifs. Hum. Immunol. 2002, 63, 701-709.
57. Ogutu, B. R., Apollo, O. J., McKinney, D., Okoth, W. et al., Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western Kenya. PLoS One 2009, 4, e4708.